Stereotaxis Company Profile (NASDAQ:STXS)

About Stereotaxis (NASDAQ:STXS)

Stereotaxis logoStereotaxis, Inc. is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab. The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information. The Company's Epoch solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The Niobe ES remote magnetic navigation system includes the Navigant software user interface and the QuikCAS catheter advancement system. The Vdrive robotic navigation system with Niobe ES magnetic navigation system provides navigation and stability for diagnostic and ablation devices.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:STXS
  • CUSIP: N/A
  • Web:
  • Market Cap: $12.85 million
  • Outstanding Shares: 22,059,000
Average Prices:
  • 50 Day Moving Avg: $0.58
  • 200 Day Moving Avg: $0.60
  • 52 Week Range: $0.47 - $1.43
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.39
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $30.49 million
  • Price / Sales: 0.41
  • Book Value: ($0.89) per share
  • Price / Book: -0.64
  • EBIDTA: ($6,230,000.00)
  • Net Margins: 16.87%
  • Return on Assets: 23.63%
  • Average Volume: 25,940 shs.
  • Beta: 3.07
  • Short Ratio: 2.4
Frequently Asked Questions for Stereotaxis (NASDAQ:STXS)

What is Stereotaxis' stock symbol?

Stereotaxis trades on the NASDAQ under the ticker symbol "STXS."

How were Stereotaxis' earnings last quarter?

Stereotaxis Inc (NASDAQ:STXS) posted its quarterly earnings results on Monday, May, 8th. The company reported $0.01 EPS for the quarter. The company had revenue of $6.98 million for the quarter. View Stereotaxis' Earnings History.

Who are some of Stereotaxis' key competitors?

Who are Stereotaxis' key executives?

Stereotaxis' management team includes the folowing people:

  • David Fischel, Chairman of the Board, Acting Chief Executive Officer
  • Martin C. Stammer, Chief Financial Officer, IR Contact Officer
  • Susan S. Lanigan, Executive Vice President, General Counsel
  • Karen W. Duros, Senior Vice President, Secretary
  • David A. Giffin, Vice President - Human Resources
  • Nathan Fischel M.D., Director
  • Joseph E. Kiani, Director
  • Arun Swarup Menawat Ph.D., Director
  • David W. Benfer, Independent Director
  • Robert J. Messey, Independent Director

How do I buy Stereotaxis stock?

Shares of Stereotaxis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Stereotaxis' stock price today?

One share of Stereotaxis stock can currently be purchased for approximately $0.57.

MarketBeat Community Rating for Stereotaxis (NASDAQ STXS)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  19
MarketBeat's community ratings are surveys of what our community members think about Stereotaxis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Stereotaxis (NASDAQ:STXS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Stereotaxis (NASDAQ:STXS)
No equities research coverage for this company has been tracked by


Earnings History for Stereotaxis (NASDAQ:STXS)
Earnings by Quarter for Stereotaxis (NASDAQ:STXS)
Earnings History by Quarter for Stereotaxis (NASDAQ STXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q1 2017$0.01$6.98 millionViewListenView Earnings Details
5/9/2016Q1($0.11)$9.50 million$8.60 millionViewListenView Earnings Details
2/22/2016Q4($0.10)$9.80 million$9.20 millionViewListenView Earnings Details
11/3/2015Q3($0.05)$8.90 million$9.30 millionViewListenView Earnings Details
8/4/2015Q215($0.12)$120.60 million$9.66 millionViewN/AView Earnings Details
5/6/2015Q115($0.15)$8.40 million$9.50 millionViewListenView Earnings Details
2/25/2015Q414$0.04$9.10 million$9.80 millionViewListenView Earnings Details
5/6/2014Q1($0.16)$8.40 million$8.40 millionViewListenView Earnings Details
2/25/2014Q4($0.19)$12.20 million$9.10 millionViewListenView Earnings Details
11/12/2013Q3($0.26)$9.70 million$10.80 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.59)($0.37)$10.80 million$9.70 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.50)($0.61)$12.00 million$8.40 millionViewListenView Earnings Details
11/5/2012Q312($0.72)($0.33)$10.30 million$11.60 millionViewN/AView Earnings Details
3/5/2012($0.14)($0.10)ViewN/AView Earnings Details
11/7/2011($0.16)($0.13)ViewN/AView Earnings Details
8/8/2011($0.12)($0.18)ViewN/AView Earnings Details
5/2/2011($0.13)($0.17)ViewN/AView Earnings Details
2/28/2011($0.11)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Stereotaxis (NASDAQ:STXS)
Current Year EPS Consensus Estimate: $-2.03 EPS
Next Year EPS Consensus Estimate: $-1.46 EPS


Dividend History for Stereotaxis (NASDAQ:STXS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Stereotaxis (NASDAQ:STXS)
Insider Trades by Quarter for Stereotaxis (NASDAQ:STXS)
Insider Trades by Quarter for Stereotaxis (NASDAQ:STXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2015Fred A MiddletonDirectorSell26,064$1.57$40,920.48View SEC Filing  
6/12/2015Fred A MiddletonDirectorSell16,273$1.61$26,199.53View SEC Filing  
6/9/2015Fred A MiddletonDirectorSell106,876$1.65$176,345.40View SEC Filing  
3/13/2015David BenferDirectorBuy3,000$1.95$5,850.00View SEC Filing  
12/12/2014William C Mills IIICEOBuy10,000$1.45$14,500.00View SEC Filing  
12/9/2014Fred A MiddletonDirectorSell8,551$1.51$12,912.01View SEC Filing  
12/5/2014William C Mills IIICEOBuy10,000$1.43$14,300.00View SEC Filing  
12/3/2014Fred A MiddletonDirectorSell15,809$1.59$25,136.31View SEC Filing  
8/11/2014William C Mills IIICEOBuy10,000$2.75$27,500.00View SEC Filing  
3/13/2014Fred A MiddletonDirectorSell24,302$4.21$102,311.42View SEC Filing  
8/23/2013Fred A MiddletonDirectorSell14,600$3.67$53,582.00View SEC Filing  
8/20/2013Christopher D AlafiMajor ShareholderSell261,241$3.74$977,041.34View SEC Filing  
8/7/2013Fred A MiddletonDirectorSell78,974$10.13$800,006.62View SEC Filing  
11/30/2012Fred A MiddletonDirectorBuy24,360$1.53$37,270.80View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Stereotaxis (NASDAQ:STXS)
Latest Headlines for Stereotaxis (NASDAQ:STXS)
DateHeadline logoPrincess Grace Hospital Publishes Data Demonstrating More Rapid Transmural Lesion Formation Utilizing Stereotaxis Robotic Technology - July 26 at 8:26 AM logoStereotaxis Receives Second Odyssey Vision™ System Orders from Two Leading Heart Hospitals - July 11 at 3:54 PM logoStereotaxis Launches the e-Contact™ Module in Europe - June 15 at 4:27 PM logoStereotaxis, Inc. :STXS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017 - May 27 at 6:03 AM logoStereotaxis Inc (STXS) Releases Quarterly Earnings Results - May 9 at 11:48 AM logoEdited Transcript of STXS earnings conference call or presentation 8-May-17 2:00pm GMT - May 9 at 10:14 AM logoInvestor Network: Stereotaxis, Inc. to Host Earnings Call - May 8 at 10:54 AM logoStereotaxis Reports 2017 First Quarter Financial Results - May 8 at 10:54 AM logoPositive Media Coverage Extremely Likely to Impact Stereotaxis (STXS) Stock Price - April 28 at 4:32 PM logoStereotaxis to Report First Quarter 2017 Financial Results on May 8, 2017 - April 27 at 8:30 PM logoStereotaxis’ Leadership in Robotic Cardiac Ablation to be Showcased at Heart Rhythm 2017 and First Annual Meeting of Society for Cardiac Robotic Navigation (Americas) - April 25 at 9:34 AM logoSTEREOTAXIS, INC. Files SEC form 10-K, Annual Report - March 16 at 8:53 PM logoClinical Study Validates Efficiencies of Stereotaxis Niobe® ES System Compared to Niobe II System - March 14 at 9:14 AM logoStereotaxis to Present at 29th Annual ROTH Conference - March 7 at 7:54 PM logoSTEREOTAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events - March 2 at 10:27 AM logoFirst Site in Japan to Install Stereotaxis Technology Completes 250 Procedures - February 23 at 8:16 PM logoMontreal Heart Institute Implements Stereotaxis Technologies - February 16 at 7:51 PM logoStereotaxis Announces Management Transition and 2016 Financial Results - February 6 at 8:08 PM logoCortex-based medical device maker's CEO resigns - February 6 at 8:08 PM logoStereotaxis Launches Interface between Niobe® ES System and Philips’ State-of-the-art X-ray System - December 15 at 6:33 AM logoQ3 2016 Stereotaxis Inc Earnings Release - After Market Close - November 7 at 11:50 AM logoSTEREOTAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers - November 1 at 12:15 PM logoStereotaxis Technologies to be Highlighted at Society for Cardiac Robotic Navigation’s Inaugural Meeting in Amsterdam - October 18 at 11:47 AM logoSTEREOTAXIS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of - September 30 at 11:43 AM logoSTEREOTAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitiv - September 28 at 7:16 PM logoStereotaxis Announces Multiple Positive Strategic Updates - September 27 at 12:07 PM logoSTEREOTAXIS, INC. Financials - August 23 at 7:44 PM logoStereotaxis posts wider loss as system sales plummet - August 12 at 7:45 PM logoQ2 2016 Stereotaxis Inc Earnings Release - After Market Close - August 9 at 10:57 AM logo9:20 am Stereotaxis up ~19% after announcing that Texas Children's Hospital in Houston has installed its Niobe ES system - July 8 at 9:20 AM logoSTEREOTAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S - May 25 at 5:08 PM logoSTEREOTAXIS, INC. Files SEC form 10-Q, Quarterly Report - May 11 at 4:41 PM



Stereotaxis (STXS) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by Staff